8-K
filed February 3, 2026, 6:59 PM ET
ticker DRMA
CIK 0001853816
other
confidence high
sentiment neutral
materiality 0.25
Dermata Therapeutics dismisses Baker Tilly, appoints CBIZ CPAs as new auditor
Dermata Therapeutics, Inc.
- Baker Tilly dismissed as independent auditor effective January 31, 2026.
- CBIZ CPAs (formerly Mayer Hoffman McCann) appointed February 2, 2026.
- No disagreements with Baker Tilly on accounting principles or disclosures.
- Baker Tilly's prior reports included a going-concern explanatory paragraph.
- CBIZ CPAs previously served as Dermata's auditor from 2016 to 2023.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-004905
- form_type
- 8-K
- ticker
- DRMA
- cik
- 0001853816
- company_name
- Dermata Therapeutics, Inc.
- filed_at
- 2026-02-03T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.546176+00:00
- generated_at
- 2026-05-16T05:23:41.858498+00:00
- sec_items
- ["4.01", "9.01"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.25
- calibrated_materiality_score
- 0.25
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-004905
- json_url
- https://secwatch.observer/filing/0001493152-26-004905.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-004905.md
- text_url
- https://secwatch.observer/filing/0001493152-26-004905.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/0001493152-26-004905-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
QMCI
Quotemedia dismisses MNP LLP, appoints GreenGrowth CPAs as auditor
QUOTEMEDIA INC
April 14, 2026, 7:59 PM ET
other
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other
similar materiality
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
(b) Appointment of New Independent Registered Public Accounting Firm On April 9, 2026, the Company appointed GreenGrowth CPAs (“GreenGrowth”) as the Company’s new independent registered public accounting.
Filing page
SEC filing
QWTR
Quest Water Global changes auditor to KAN Accounting Solutions after Fruci resignation
Quest Water Global, Inc.
May 28, 2026, 7:33 PM ET
other
Items 4.01
same fact type: auditor_change
same SEC item: 4.01
same event type: other
similar materiality
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
Fruci resigned as the Company’s independent accountant at the Company’s request on May 5, 2026.
Filing page
SEC filing
GRVE
Groove Botanicals replaces auditor; prior reports noted going concern doubts
GROOVE BOTANICALS INC.
May 22, 2026, 1:58 PM ET
other
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
On May 13, 2026, M. S. Madhava Rao, Chartered Accountant (PCAOB ID 06662) (“Madhava Rao”) resigned as the independent registered public accounting firm of GROOVE BOTANICALS, INC., a Nevada corporation (the “Company”), effective immediately.
Filing page
SEC filing
RMIX
Suncrete changes auditor to Grant Thornton; prior auditor flagged going concern
Suncrete, Inc.
May 21, 2026, 4:26 PM ET
other
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
As previously disclosed, on April 8, 2026, the audit committee of the board of directors of the Company (the “Board”) approved the engagement of Grant Thornton LLP (“Grant Thornton”) as the independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending December 31, 2026.
Filing page
SEC filing
HRZN
Horizon Tech Finance dismisses RSM, appoints Grant Thornton as auditor
Horizon Technology Finance Corp
May 14, 2026, 4:32 PM ET
other
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
the Board approved the appointment of Grant Thorton LLP (“GT”) to serve as the Company’s independent registered accounting firm to audit the Company’s consolidated financial statements for the fiscal year ended December 31, 2026.
Filing page
SEC filing
BMNR
Bitmine Immersion Technologies dismisses Bush & Associates, appoints KPMG as auditor
BITMINE IMMERSION TECHNOLOGIES, INC.
May 1, 2026, 7:59 PM ET
other
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
pproved the dismissal of Bush & Associates CPA LLC (“ Bush & Associates ”) as the Company’s independent
registered public accounting firm.
Filing page
SEC filing
HGTXU
Hugoton Royalty Trust dismisses auditor Grant Thornton; cites cash constraints, no replacement sought
HUGOTON ROYALTY TRUST
April 17, 2026, 7:59 PM ET
other
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
On April 16, 2026, Hugoton Royalty Trust (the “Trust”) dismissed Grant Thornton LLP (“GT”) as its independent registered public accounting firm.
Filing page
SEC filing
CRWE
Crown Equity Holdings appoints Vilki & Co. as auditor; prior report includes going concern
Crown Equity Holdings, Inc.
April 17, 2026, 7:59 PM ET
other
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other
This filing
On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
Comparable filing
On April 15, 2026, (the “Engagement Date”), the Company engaged Vilki & Co. (“Vilki”) as its independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 to replace L J Soldinger Associates, LLC (“Soldinger”).
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.